Drugs & TargetsFree Philips and Illumina to co-develop integrated genomics solutions for oncology January 13, 2017Vol.43 No.02
Drugs & TargetsFree Tecentriq receives priority review for treatment of urothelial carcinoma January 13, 2017Vol.43 No.02
Drugs & TargetsFree EMD Serono and MD Anderson enter three-year collaboration January 13, 2017Vol.43 No.02
Drugs & TargetsFree MD Anderson and Deerfield Management create company to inhibit autophagy January 13, 2017Vol.43 No.02
Drugs & TargetsFree Cologuard earns positive review from Blue Cross Blue Shield Association January 13, 2017Vol.43 No.02
Drugs & TargetsFree FDA accepts BLA for Mylan and Biocon’s biosimilar Trastuzumab January 13, 2017Vol.43 No.02
Drugs & TargetsFree FDA releases guidance on nonproprietary naming of biologics January 13, 2017Vol.43 No.02
Drugs & TargetsFree Strata Trial study launched with UNC, Alabama cancer centers January 06, 2017Vol.43 No.01
Drugs & TargetsFree Foundation Medicine receives FDA approval as companion diagnostic January 06, 2017Vol.43 No.01
